Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms

  • Post author:PacConAdmin
  • Post published:May 22, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration’s Center for Devices and Radiological Health has issued letters to two third-party medical device testing firms in China. Source: FDA Press Releases

Continue ReadingFDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms

FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation

  • Post author:PacConAdmin
  • Post published:May 22, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration (FDA) today announced the seizure of nearly two million units of unauthorized e-cigarette products in Chicago, with an estimated retail value of $33.8 million.…

Continue ReadingFDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation

FDA takes steps to enhance state importation programs to help lower prescription drug prices

  • Post author:PacConAdmin
  • Post published:May 21, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective and more affordable drugs for American patients, as part of its…

Continue ReadingFDA takes steps to enhance state importation programs to help lower prescription drug prices

FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

  • Post author:PacConAdmin
  • Post published:May 16, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration cleared the first blood test, which measures two key biomarkers, to aid in diagnosing Alzheimer’s disease in people exhibiting symptoms of the disease. Source:…

Continue ReadingFDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public

  • Post author:PacConAdmin
  • Post published:May 16, 2025
  • Post category:Uncategorized

FDA’s Commissioner Martin A. Makary, M.D., M.P.H., will lead the inaugural meeting of an independent panel of scientific experts to discuss talc exposure in a public forum on Tuesday, May…

Continue ReadingFDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public

FDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy

  • Post author:PacConAdmin
  • Post published:May 15, 2025
  • Post category:Uncategorized

The U.S. Food and Drug Administration today is taking a major step to increase transparency and ensure the safety of chemicals in our food Source: FDA Press Releases

Continue ReadingFDA Advances Robust, Transparent Post-Market Chemical Review Program to Keep Food Supply Safe and Healthy

FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market

  • Post author:PacConAdmin
  • Post published:May 13, 2025
  • Post category:Uncategorized

FDA begins action to remove unapproved fluoride drug products from the market for the well-being of children Source: FDA Press Releases

Continue ReadingFDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market

HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula

  • Post author:PacConAdmin
  • Post published:May 13, 2025
  • Post category:Uncategorized

Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced the next steps in Operation Stork Speed Source: FDA Press Releases

Continue ReadingHHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

  • Post author:PacConAdmin
  • Post published:May 13, 2025
  • Post category:Uncategorized

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers Source: FDA Press Releases

Continue ReadingHHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program

  • Post author:PacConAdmin
  • Post published:May 9, 2025
  • Post category:Uncategorized

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program Source: FDA Press Releases

Continue ReadingFDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program
  • 1
  • 2
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company